Soy Isoflavones: No Evidence of Endometrial Harm at 3 YearsSoy Isoflavones: No Evidence of Endometrial Harm at 3 Years
A study that found soy isoflavone supplements ineffective in preventing bone loss now shows that at least they do not appear harmful over the long term. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 19, 2014 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
Genistein in soybeans may Inhibit HIV Infection
A compound found in soybeans may become an effective HIV treatment without the drug resistance issues faced by current therapies, according to new research by George Mason University researchers. It's in the early stages, but genistein, derived from soybeans and other plants, shows promise in inhibiting the HIV infection, says Yuntao Wu, a professor with the George Mason-based National Center for Biodefense and Infectious Diseases and the Department of Molecular and Microbiology. Still, that doesn't mean people should begin eating large amounts of soy products... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 31, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news
Are SOYA BEANS the key to wrinkle-free skin? Hormone in the vegetable can keep us looking youthful, say scientists
Genistein, a natural plant-hormone in soya, has been found to boost the production of collagen, the protein which gives skin its elasticity, according to the that depletes with age, according to the cosmetic firm Swisscode. (Source: the Mail online | Health)
Source: the Mail online | Health - April 22, 2013 Category: Consumer Health News Source Type: news
GCP Therapy May Extend Life Expectancy Of Prostate Cancer Patients With Low Response To Androgen-Deprivation Therapy
A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers have found. Men with prostate cancer that has spread to other parts of the body, known as metastatic cancer, and who have had their testosterone lowered with drug therapy are most likely to benefit. The study, recently published in Endocrine-Related Cancer, was conducted in prostate cancer cells and in mice... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 24, 2013 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
GCP Could Lengthen Life Expectancy Of Prostate Cancer Patients
The life expectancy of some prostate cancer patients could be lengthened with a natural, non-toxic substance called genistein-combined polysaccharide (GCP). The finding came from a new study on prostate cancer cells and mice conducted by researchers from University of California, Davis, and was published in Endocrine-Related Cancer. The men who have the highest probability to benefit from GCP are those with metastatic prostate cancer - cancer that has spread to other parts of the body - and have already used drug therapy to lower their testosterone levels... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 23, 2013 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
Mushroom-supplemented soybean extract shows therapeutic promise for advanced prostate cancer
(University of California - Davis Health System) A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers have found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2013 Category: Global & Universal Source Type: news
Increasing effectiveness of androgen deprivation
Mooso et al. showed that Filamin A (FlnA) nuclear localisation induced apoptosis in castration-resistant prostate cancer (CRPC) cells during androgen deprivation therapy (ADT). The natural product genistein-combined polysaccharide (GCP) had a similar effect, by inducing FlnA cleavage and nuclear localisation. In a mouse model of prostate cancer recurrence, GCP, but not vehicle, impeded relapse following castration. These results demonstrate the efficacy of GCP in promoting FlnA nuclear localisation in prostate cancer. Mooso et al. (2013) Endocrine-Related Cancer 19, 759–777.
Read the full article at DOI: 10.1530/ERC...
Source: Society for Endocrinology - January 8, 2013 Category: Endocrinology Source Type: news
